Rekhtman et al. [18] sorted out 18 patients with SMARCA4-UT and found that 50% patients (9/18) had typical NSCLC gene mutations, including STK11 (n = 6), KEAP1 (n = 4), and KRAS (n = 5) mutations. This evidence concerns the gene STK11 and non-small cell lung carcinoma.